These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 28068860)

  • 1. Does adjunctive use of progesterone in women with cerclage improve prevention of preterm birth?
    Sinkey RG; Garcia MR; Odibo AO
    J Matern Fetal Neonatal Med; 2018 Jan; 31(2):202-208. PubMed ID: 28068860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Cervical Cerclage and Vaginal Progesterone in the Treatment of Cervical Incompetence with/without Preterm Birth History.
    Wang SW; Ma LL; Huang S; Liang L; Zhang JR
    Chin Med J (Engl); 2016 Nov; 129(22):2670-2675. PubMed ID: 27823998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomised trial to compare 200 mg micronised progesterone effervescent vaginal tablet daily with 250 mg intramuscular 17 alpha hydroxy progesterone caproate weekly for prevention of recurrent preterm birth.
    Shambhavi S; Bagga R; Bansal P; Kalra J; Kumar P
    J Obstet Gynaecol; 2018 Aug; 38(6):800-806. PubMed ID: 29557230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of progesterone, cerclage and pessary in preventing preterm birth in twin pregnancies: A systematic review and network meta-analysis.
    D'Antonio F; Berghella V; Di Mascio D; Saccone G; Sileo F; Flacco ME; Odibo AO; Liberati M; Manzoli L; Khalil A
    Eur J Obstet Gynecol Reprod Biol; 2021 Jun; 261():166-177. PubMed ID: 33946019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of different progesterone preparations with preterm birth prevention.
    Krispin E; Hadar E; Chen R; Wiznitzer A; Kaplan B
    J Matern Fetal Neonatal Med; 2019 Oct; 32(20):3452-3457. PubMed ID: 29699436
    [No Abstract]   [Full Text] [Related]  

  • 6. Outcomes of ultrasound and physical-exam based cerclage: assessment of risk factors and the role of adjunctive progesterone in preventing preterm birth-a retrospective cohort study.
    Lavie M; Shamir-Kaholi N; Lavie I; Doyev R; Yogev Y
    Arch Gynecol Obstet; 2020 Apr; 301(4):981-986. PubMed ID: 32170408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent progestogen and cerclage to reduce preterm birth: a multicenter international retrospective cohort.
    Tolosa JE; Boelig RC; Bell J; Martínez-Baladejo M; Stoltzfus J; Mateus J; Quiñones JN; Galeano-Herrera S; Pereira L; Burwick R; López-Torres L; Valencia C; Berghella V;
    Am J Obstet Gynecol MFM; 2024 Jul; 6(7):101351. PubMed ID: 38513806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaginal progesterone vs. cervical cerclage for the prevention of preterm birth in women with a sonographic short cervix, previous preterm birth, and singleton gestation: a systematic review and indirect comparison metaanalysis.
    Conde-Agudelo A; Romero R; Nicolaides K; Chaiworapongsa T; O'Brien JM; Cetingoz E; da Fonseca E; Creasy G; Soma-Pillay P; Fusey S; Cam C; Alfirevic Z; Hassan SS
    Am J Obstet Gynecol; 2013 Jan; 208(1):42.e1-42.e18. PubMed ID: 23157855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical cerclage for singleton pregnant patients on vaginal progesterone with progressive cervical shortening.
    Enakpene CA; DiGiovanni L; Jones TN; Marshalla M; Mastrogiannis D; Della Torre M
    Am J Obstet Gynecol; 2018 Oct; 219(4):397.e1-397.e10. PubMed ID: 30017683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerclage Plus Adjuvant Vaginal Progesterone for Preterm Birth Prevention in Patients with a Short or Dilated Cervix without Prior Preterm Birth.
    Hart JM; Macharia A; Modest AM; Johnson KM; Lauring J; Nicasio E; Hacker MR; Spiel MH
    Am J Perinatol; 2024 Sep; 41(12):1595-1603. PubMed ID: 38698597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaginal progesterone, oral progesterone, 17-OHPC, cerclage, and pessary for preventing preterm birth in at-risk singleton pregnancies: an updated systematic review and network meta-analysis.
    Jarde A; Lutsiv O; Beyene J; McDonald SD
    BJOG; 2019 Apr; 126(5):556-567. PubMed ID: 30480871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerclage, progesterone and α-hydroxyprogeterone caproate treatment in women at risk for preterm delivery.
    Haram K; Mortensen JH; Morrison JC
    J Matern Fetal Neonatal Med; 2014 Nov; 27(16):1710-5. PubMed ID: 24678618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of progesterone, cerclage and pessary for preventing preterm birth in singleton pregnancies: a systematic review and network meta-analysis.
    Jarde A; Lutsiv O; Park CK; Beyene J; Dodd JM; Barrett J; Shah PS; Cook JL; Saito S; Biringer AB; Sabatino L; Giglia L; Han Z; Staub K; Mundle W; Chamberlain J; McDonald SD
    BJOG; 2017 Jul; 124(8):1176-1189. PubMed ID: 28276151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progesterone and preterm birth prevention: translating clinical trials data into clinical practice.
    Society for Maternal-Fetal Medicine Publications Committee, with assistance of Vincenzo Berghella
    Am J Obstet Gynecol; 2012 May; 206(5):376-86. PubMed ID: 22542113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaginal progesterone combined with cervical pessary: A chance for pregnancies at risk for preterm birth?
    Stricker N; Timmesfeld N; Kyvernitakis I; Goerges J; Arabin B
    Am J Obstet Gynecol; 2016 Jun; 214(6):739.e1-739.e10. PubMed ID: 26692180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison the efficacy of vaginal progesterone
    Alavi A; Ranjbar A; Atighpoor F; Zare S
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):7438-7444. PubMed ID: 34470137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical Cerclage versus Vaginal Progesterone for Management of Short Cervix in Low-Risk Women.
    Wood AM; Dotters-Katz SK; Hughes BL
    Am J Perinatol; 2019 Jan; 36(2):111-117. PubMed ID: 30112757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preterm birth prevention in twin pregnancies with progesterone, pessary, or cerclage: a systematic review and meta-analysis.
    Jarde A; Lutsiv O; Park CK; Barrett J; Beyene J; Saito S; Dodd JM; Shah PS; Cook JL; Biringer AB; Giglia L; Han Z; Staub K; Mundle W; Vera C; Sabatino L; Liyanage SK; McDonald SD
    BJOG; 2017 Jul; 124(8):1163-1173. PubMed ID: 28176485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaginal progesterone vs intramuscular 17-hydroxyprogesterone caproate for prevention of recurrent preterm birth: a randomized controlled trial.
    Boelig RC; Schoen CN; Frey H; Gimovsky AC; Springel E; Backley S; Berghella V
    Am J Obstet Gynecol; 2022 May; 226(5):722.e1-722.e12. PubMed ID: 35189093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of 17α-hydroxyprogesterone caproate on preterm birth in women with an ultrasound-indicated cerclage.
    Rafael TJ; Mackeen AD; Berghella V
    Am J Perinatol; 2011 May; 28(5):389-94. PubMed ID: 21380984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.